Neuralink is one of a growing group of startups developing brain implants. Neuralink Corp.'s brain-computer device has been implanted in a third patient and the company has plans for about 20 to ...

Prime Minister Narendra Modi on Thursday released the genome sequencing data of 10,000 Indian nationals and said it will be a milestone in the field of biotechnology research. The Genome India ...

Uni­corn start­up Tran­scar­ent has bought up a pub­licly trad­ed ri­val as it looks to ex­pand as a health nav­i­ga­tion gi­ant in one of the first … ...

JMP Securities analyst Reni Benjamin maintained a Hold rating on Sana Biotechnology (SANA – Research Report) today. The company’s shares opened today at $1.75. Discover outperforming stocks ...

The aim of this Fund is to provide long-term capital growth over a period of 5 years or more. The Fund invests in shares of listed companies, principally in the biotechnology, genomic and medical ...

Biotechnology contributes to this aspect of the plastics industry while providing end-of-life waste management solutions via enzymatic recycling, facilitating monomer recovery under milder conditions ...

Dr Kalyankar, a Rotarian from the Rotary Club of Kharghar Midterm, Navi Mumbai, presented the paper titled Brain Cancer and Ayurvedic Treatment’. Read Also 7 Ayurvedic Tips To Manage Blood Sugar ...

The link between poor sleep and mental health problems could be related to deficits in brain regions that keep unwanted thoughts out of mind, according to research from the University of East ...

Based on new brain mapping research funded by the National Institutes of Health (NIH), scientists have discovered that not all cell types in the brain age in the same way. They found that some ...

Two Philadelphia biotech companies scored approval in 2024 for first-of-their-kind gene therapy treatments for solid cancer tumors and melanoma. Those achievements by Iovance Biotherapeutics and ...

WP-1066 is under clinical development by Moleculin Biotech and currently in Phase II for Brain Tumor. According to GlobalData, Phase II drugs for Brain Tumor have a 22% phase transition success rate ...